17-11-2021 19:30 via medpagetoday.com

Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agent

(MedPage Today) -- Bentracimab reversed the antiplatelet effects of P2Y12 inhibitor ticagrelor (Brilinta) in the vast majority of patients on dual anti-platelet therapy (DAPT) who were set to undergo urgent surgery or treatment for hemorrhage...
Read more »